GLP-1 drugs connected to rare vision issue, researchers say

Researchers at Rutgers University have identified a potential link between GLP-1 drugs, commonly used for diabetes and weight loss, and a rare but serious eye condition called ischemic optic neuropathy. This condition can lead to vision loss, raising concerns about the safety profile of these medications. As GLP-1 drugs grow in popularity, this study underscores the importance of ongoing research to fully understand their long-term effects, especially on critical systems like vision.